PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.2109
-0.0070 (-3.21%)
At close: Aug 28, 2026, 4:00 PM EDT
0.2136
+0.0027 (1.28%)
After-hours: Aug 28, 2026, 7:27 PM EDT
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $11.8 million as of August 28, 2026. Its market cap has decreased by -80.22% in one year.
Market Cap
11.80M
Enterprise Value
10.57M
1-Year Change
-80.22%
Ranking
Category
Stock Price
$0.21
ChartMarket Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has decreased from $45.51M to $11.80M, a decrease of -74.06%. That is a compound annual growth rate of -16.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 11.80M | -71.98% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 13.41M |
| BioLineRx | 13.26M |
| Phio Pharmaceuticals | 13.01M |
| Kiora Pharmaceuticals | 11.77M |
| Senti Biosciences Holdings | 11.76M |
| Theriva Biologics | 11.59M |
| Aspire Biopharma Holdings | 11.59M |
| Vistagen Therapeutics | 11.40M |